Kraig Biocraft Laboratories produces first roll of pure Dragon Silk fabric for U.S. Army

ANN ARBOR, Mich.--()--Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers announces today that it has just finished the production of its first roll of pure Dragon Silk fabric, marking the first time that the Company’s proprietary recombinant spider silk fibers were used to create a 100% pure woven silk fabric.

“Dragon Silk, which started as a simple idea in the lab for a better performing silk, is now on the verge of demonstrating its capability to provide lifesaving performance blended with high flexibility and user comfort”

The Company is now preparing to assemble the Dragon Silk material into finalized ballistic shoot packs, per the U.S. Army specifications. This material is destined for ballistic performance testing, under the Company’s contract with the U.S. Army, to evaluate its potential for protective apparel applications.

“Dragon Silk, which started as a simple idea in the lab for a better performing silk, is now on the verge of demonstrating its capability to provide lifesaving performance blended with high flexibility and user comfort,” said Jon Rice COO. “What a proud moment for the Company and all of our employees, as we prepare to process this first roll of Dragon Silk fabric into test samples for the U.S. Army and to assess its ability to assist in protecting the brave men and women of our armed forces, who dedicate themselves to protecting all of us.”

The Company previously developed sample products, in pure and blended knit configurations using its Monster Silk materials, including shirts and gloves. Today’s announcement marks the first time the Company’s newer and stronger Dragon Silk will be transitioned into an end product.

To view the most recent edition of Kraig’s Spider Sense quarterly newsletter and/or to sign up for Company alerts, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Contacts

Hansel Capital, LLC
Ben Hansel, 720-288-8495
ir@KraigLabs.com

Recent Stories

RSS feed for Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc.